Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Shuomin Zhu, Min-Liang Si, Hailong Wu, et al.
Journal of Biological Chemistry (2007) Vol. 282, Iss. 19, pp. 14328-14336
Open Access | Times Cited: 1086

Showing 1-25 of 1086 citing articles:

Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
Nature Reviews Genetics (2009) Vol. 10, Iss. 10, pp. 704-714
Open Access | Times Cited: 2895
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
Irfan A. Asangani, Suhail Ahmed Kabeer Rasheed, Dessislava A. Nikolova, et al.
Oncogene (2007) Vol. 27, Iss. 15, pp. 2128-2136
Open Access | Times Cited: 1833
MicroRNAs in Cancer
Ramiro Garzon, George A. Calin, Carlo M. Croce
Annual Review of Medicine (2009) Vol. 60, Iss. 1, pp. 167-179
Closed Access | Times Cited: 1744
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane, Paul R. Murphy
Current Genomics (2010) Vol. 11, Iss. 7, pp. 537-561
Open Access | Times Cited: 1706
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
Aaron J. Schetter, Suet Yi Leung, Jane J. Sohn, et al.
JAMA (2008) Vol. 299, Iss. 4
Open Access | Times Cited: 1575
MicroRNAs in Cancer
Gianpiero Di Leva, Michela Garofalo, Carlo M. Croce
Annual Review of Pathology Mechanisms of Disease (2013) Vol. 9, Iss. 1, pp. 287-314
Open Access | Times Cited: 1536
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon, Guido Marcucci, Carlo M. Croce
Nature Reviews Drug Discovery (2010) Vol. 9, Iss. 10, pp. 775-789
Open Access | Times Cited: 1441
MicroRNAs in Cancer
Yong Sun Lee, Anindya Dutta
Annual Review of Pathology Mechanisms of Disease (2008) Vol. 4, Iss. 1, pp. 199-227
Open Access | Times Cited: 1375
MicroRNA Signatures in Human Ovarian Cancer
Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva, et al.
Cancer Research (2007) Vol. 67, Iss. 18, pp. 8699-8707
Open Access | Times Cited: 1364
SMAD proteins control DROSHA-mediated microRNA maturation
Brandi N. Davis‐Dusenbery, Aaron C. Hilyard, Giorgio Lagna, et al.
Nature (2008) Vol. 454, Iss. 7200, pp. 56-61
Open Access | Times Cited: 1207
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
The Journal of Experimental Medicine (2011) Vol. 208, Iss. 7, pp. 1339-1350
Open Access | Times Cited: 1172
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells
Lisa B. Frankel, Nanna R. Christoffersen, Anders J. Skanderup, et al.
Journal of Biological Chemistry (2007) Vol. 283, Iss. 2, pp. 1026-1033
Open Access | Times Cited: 1130
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li‐Xu Yan, Xiu-Fang Huang, Qiong Shao, et al.
RNA (2008) Vol. 14, Iss. 11, pp. 2348-2360
Open Access | Times Cited: 1119
MicroRNAs in Development and Disease
Danish Sayed, Maha Abdellatif
Physiological Reviews (2011) Vol. 91, Iss. 3, pp. 827-887
Closed Access | Times Cited: 1047
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu, Hailong Wu, Fangting Wu, et al.
Cell Research (2008) Vol. 18, Iss. 3, pp. 350-359
Open Access | Times Cited: 1010
miR‐21: a small multi‐faceted RNA
Anna M. Krichevsky, Galina Gabriely
Journal of Cellular and Molecular Medicine (2008) Vol. 13, Iss. 1, pp. 39-53
Open Access | Times Cited: 979
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li, Tariq M. Rana
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 8, pp. 622-638
Closed Access | Times Cited: 953
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Galina Gabriely, Thomas Würdinger, Santosh Kesari, et al.
Molecular and Cellular Biology (2008) Vol. 28, Iss. 17, pp. 5369-5380
Open Access | Times Cited: 865
MicroRNAs — the micro steering wheel of tumour metastases
Milena S. Nicoloso, Riccardo Spizzo, Masayoshi Shimizu, et al.
Nature reviews. Cancer (2009) Vol. 9, Iss. 4, pp. 293-302
Closed Access | Times Cited: 744
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Robert Schickel, Brad M. Boyerinas, Park Sm, et al.
Oncogene (2008) Vol. 27, Iss. 45, pp. 5959-5974
Open Access | Times Cited: 712
OncomiRs: the discovery and progress of microRNAs in cancers
William C. Cho
Molecular Cancer (2007) Vol. 6, Iss. 1, pp. 60-60
Open Access | Times Cited: 697
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Zhongxin Lu, Mo‐Fang Liu, Vilius Stribinskis, et al.
Oncogene (2008) Vol. 27, Iss. 31, pp. 4373-4379
Closed Access | Times Cited: 696
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Thales Papagiannakopoulos, Alice Shapiro, Kenneth S. Kosik
Cancer Research (2008) Vol. 68, Iss. 19, pp. 8164-8172
Open Access | Times Cited: 689
MicroRNA function in cancer: oncogene or a tumor suppressor?
Sylvia Shenouda, Suresh K. Alahari
Cancer and Metastasis Reviews (2009) Vol. 28, Iss. 3-4, pp. 369-378
Closed Access | Times Cited: 666
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Aaron J. Schetter, Niels H. H. Heegaard, Curtis C. Harris
Carcinogenesis (2009) Vol. 31, Iss. 1, pp. 37-49
Open Access | Times Cited: 643
Page 1 - Next Page

Scroll to top